HAL vs NVAX · P/E 9.3, $19.05B cap vs P/E 2.5, rev $682.2M
Halliburton Company (HAL) versus Novavax Inc (NVAX) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Novavax Inc (NVAX) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported NVAX revenue for 2024-12-31 was $682.2M. Net income was -$187.5M. Revenue was down 30.7% from 2023-12-31 to 2024-12-31. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Not investment advice. Open the HAL and NVAX stock pages for the full models.
Not investment advice.